Mukta Gautam-Dhakal
Psychiatric/Mental Health · Reston, VANPI 1275034837
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.6% of the total across 369 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 14.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,697, 3.5 times the $775 reported in 2021. Among psychiatric/mental health clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 369 payments — averaging $23.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Lundbeck LLC$952
- AbbVie$925
- Takeda Pharmaceuticals U.S.A., Inc.$700
- Johnson & Johnson$654
- Axsome Therapeutics, Inc.$601
- plus $4K from 24 others
What the payments were for
- Food & beverage$8,61699%
- Education$1201%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 48 | $1,276 |
| Lundbeck LLC | 42 | $952 |
| AbbVie | 42 | $925 |
| Takeda Pharmaceuticals U.S.A., Inc. | 42 | $700 |
| Johnson & Johnson | 16 | $654 |
| Axsome Therapeutics, Inc. | 21 | $601 |
| Otsuka America Pharmaceutical, Inc. | 27 | $548 |
| Teva Pharmaceuticals USA, Inc. | 17 | $521 |
| Alkermes, Inc. | 20 | $416 |
| Vanda Pharmaceuticals Inc. | 14 | $295 |
| Bausch Health US, LLC | 12 | $271 |
| Idorsia Pharmaceuticals US Inc | 9 | $236 |
| Corium, LLC | 10 | $234 |
| Neurocrine Biosciences, Inc. | 7 | $179 |
| Supernus Pharmaceuticals, Inc. | 2 | $150 |
| Harmony Biosciences LLC | 4 | $104 |
| Jazz Pharmaceuticals Inc. | 4 | $95 |
| Ironshore Pharmaceuticals Inc. | 4 | $82 |
| Almatica Pharma LLC | 3 | $70 |
| Vertical Pharmaceuticals, LLC | 4 | $68 |
| Collegium Pharmaceutical, Inc. | 3 | $67 |
| E.r. Squibb & Sons, L.L.C. | 3 | $64 |
| Tris Pharma Inc | 3 | $55 |
| Amarin Pharma, Inc. | 3 | $41 |
| Adlon Therapeutics L.p. | 2 | $35 |
| Novartis | 2 | $28 |
| Amgen | 2 | $28 |
| Sage Therapeutics, LLC | 1 | $14 |
| Merck | 1 | $14 |
| Noven Therapeutics, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CAPLYTA$492
- SPRAVATO$397
- Auvelity$125
- QELBREE$119
- Austedo XR$118
How this compares
$8,736 in reported general payments places this provider in the 95th percentile of 1,003 psychiatric/mental health providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Vilazodone Hcl | 11 | $1,104 |
| Bupropion XlBupropion Hcl | 34 | $797 |
| Quetiapine Fumarate | 20 | $430 |
| Hydroxyzine Hcl | 21 | $356 |
| Trazodone Hcl | 28 | $294 |
| Desipramine Hcl | 24 | $265 |
| Clonazepam | 16 | $195 |
| Escitalopram Oxalate | 30 | $153 |
| Lithium Carbonate | 11 | $81 |
| Alprazolam | 26 | $39 |
| Lorazepam | 12 | $29 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Reston
- Joshua NiekranzReston$9K
- Justin RayChesapeake$127K
- Katia HallChesapeake$88K
- Christine GilmoreBedford$75K
- Sarah FaberNewport News$59K
- Kristine GarciaGlen Allen$46K
- Tonjanika BoydRichmond$40K
- Kirby PatmonRichmond$36K
- Juliana FroschAmherst$36K
- Derick ReedyNickelsville$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.